Inscription Capital, LLC Reata Pharmaceuticals Inc Transaction History

Inscription Capital, LLC

  • $613 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$25.61 - $110.96 $76,830 - $332,880
-3,000 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$100.0 - $143.02 $300,000 - $429,060
3,000 New
3,000 $302,000
Q2 2021

Aug 13, 2021
SELL
$78.27 - $151.29 $234,810 - $453,870
-3,000 Closed
0 $0
Q1 2021

May 18, 2021
BUY
$94.25 - $132.81 $282,750 - $398,430
3,000 New
3,000 $299,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email